Drugs and hepatotoxicity: a comprehensive review

Sudhakar B. Patil; Mirza S. Baig; Avinash D. Pal

doi:10.18203/2320-6012.ijrms20261373

Authors

Sudhakar B. Patil Department of Pharmacology, Government Medical College, Chhatrapati Sambhajinagar, Maharashtra, India
Mirza S. Baig Department of Pharmacology, Government Medical College, Chhatrapati Sambhajinagar, Maharashtra, India
Avinash D. Pal Department of Pharmacology, Government Medical College, Chhatrapati Sambhajinagar, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261373

Keywords:

Drugs and hepatotoxicity, Xenobiotic metabolism, Advances

Abstract

Hepatotoxicity is a leading cause of acute and chronic liver disease worldwide. It denotes liver damage resulting from exposure to pharmaceuticals, chemicals, herbal preparations, or other foreign compounds. It is a major concern in clinical practice and drug development, as liver injury is a frequent cause of treatment discontinuation and drug withdrawal. Owing to its central role in metabolism and detoxification, the liver is particularly susceptible to toxic injury. The spectrum of hepatotoxicity ranges from mild, transient elevations in liver enzymes to severe acute liver failure. This review discusses the role of the liver in xenobiotic metabolism, mechanisms of hepatotoxicity, types of liver injury, implicated drugs, diagnostic approaches, management strategies, and preventive measures. Emphasis is placed on integrating mechanistic insights with clinical applications to aid in early detection, better therapeutic strategies, and reduction of morbidity and mortality associated with hepatotoxicity.

References

Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015;25(8):416-26.

McGill MR, Jaeschke H. Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis. Pharm Res. 2013;30(9):2174-87.

Kadam R, Palkar M, Pingili RB. Mechanisms involved in the valproic acid-induced hepatotoxicity: a comprehensive review. Toxicol Mech Methods. 2025;35(6):565-80.

Tong V, Teng XW, Chang TKH, Abbott FS. Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat Hepatocytes. Toxicol Sci. 2005;86(2):436-43.

Liao J, Lu Q, Li Z, Li J, Zhao Q, Li J. Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products. Front Pharmacol. 2023;14:1122632.

Chidiac AS, Buckley NA, NF Cairns R. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opin Drug Metab Toxicol. 2023;19(5):297-317.

Andrade V, Guerra M, Jardim C, Melo F, Silva W, Ortega JM, et al. Nucleoplasmic calcium regulates cell proliferation through legumain. J Hepatol. 2011;55(3):626-35.

Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60(4):1399-408.

Hoofnagle JH, Björnsson ES. Drug-Induced Liver Injury - Types and Phenotypes. N Engl J Med. 2019;381(3):264-73.

Reuben A, Koch DG, Lee WM. Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study. Hepatology. 2010;52(6):2065-76.

Jaeschke H. Mechanisms of Hepatotoxicity. Toxicol Sci. 2002;65(2):166-76.

Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4(6):489-99.

Fontana RJ. Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives. Gastroenterology. 2014;146(4):914-28.

Watkins P. Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury. Semin Liver Dis. 2009;29(04):393-9.

Heard KJ. Acetylcysteine for Acetaminophen Poisoning. N Engl J Med. 2008;359(3):285-92.

Avella DM, Li G, Schell TD, Liu D, Zhang SS, Lou X, et al. Regression of Established Hepatocellular Carcinoma Is Induced by Chemoimmunotherapy in An Orthotopic Murine Model. Hepatology. 2012;55(1):141-52.

Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323-30.

Sun C, Yang X, Tang L, Chen J. A pharmacovigilance study on drug-induced liver injury associated with antibody-drug conjugates (ADCs) based on the food and drug administration adverse event reporting system. Expert Opin Drug Saf. 2024;23(8):1049-60.

Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol. 2014;109(7):950-66.

Bernal W, Wendon J. Acute Liver Failure. N Engl J Med. 2013;369(26):2525-34.

Niu H, Alvarez-Alvarez I, CM. Artificial Intelligence: An Emerging Tool for Studying Drug-Induced Liver Injury. Liver Int. 2025;45(3):e70038.

Mostafa F, Chen M. Computational models for predicting liver toxicity in the deep learning era. Front Toxicol. 2024;5:1340860.